Biogen Inc
(BIIB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,326,500 | 2,084,800 | 1,362,000 | 1,130,700 | 1,308,000 |
| Marketable Securities | 2,568,600 | 2,231,200 | 2,434,800 | 2,454,700 | 2,120,500 |
| Receivables | 1,441,600 | 1,467,800 | 1,293,000 | 1,395,100 | 1,227,000 |
| Inventories | 1,001,600 | 1,009,700 | 996,400 | 964,600 | 893,400 |
| Other current assets | 1,393,900 | 1,298,300 | 1,361,500 | 1,256,200 | 1,151,400 |
| TOTAL | $8,732,200 | $8,091,800 | $7,447,700 | $7,201,300 | $6,700,300 |
| Non-Current Assets | |||||
| PPE Net | 2,501,800 | 2,387,000 | 2,301,800 | 2,258,900 | 2,187,600 |
| Investments And Advances | 4,165,200 | 4,336,500 | 4,630,600 | 4,284,400 | 3,868,000 |
| Intangibles | 7,477,600 | 7,289,600 | 7,134,700 | 6,930,100 | 6,748,900 |
| TOTAL | $14,144,600 | $14,013,100 | $14,067,100 | $13,473,400 | $12,804,500 |
| Total Assets | $22,876,800 | $22,104,900 | $21,514,800 | $20,674,700 | $19,504,800 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 279,800 | 274,000 | 225,900 | 271,300 | 267,400 |
| Accrued Expenses | 2,903,500 | 2,012,000 | 2,072,700 | 2,003,900 | 2,096,800 |
| TOTAL | $3,419,900 | $2,499,700 | $2,516,200 | $2,776,600 | $2,577,700 |
| Non-Current Liabilities | |||||
| Long Term Debt | 6,512,700 | 6,529,600 | 6,538,300 | 6,535,600 | 6,521,500 |
| Other Non-Current Liabilities | 723,800 | 864,800 | 952,400 | 918,300 | 908,600 |
| TOTAL | $7,328,300 | $7,490,400 | $7,594,900 | $7,570,000 | $7,552,200 |
| Total Liabilities | $10,748,200 | $9,990,100 | $10,111,100 | $10,346,600 | $10,129,900 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 215,952 | 217,575 | 219,121 | 219,052 | 218,673 |
| Common Shares | 100 | 100 | 100 | 100 | 100 |
| Retained earnings | 15,071,600 | 15,030,000 | 14,229,100 | 13,179,300 | 12,208,400 |
| Other shareholders' equity | -331,100 | -303,300 | -282,600 | -257,700 | -221,600 |
| TOTAL | $12,128,600 | $12,114,800 | $11,403,700 | $10,328,100 | $9,374,900 |
| Total Liabilities And Equity | $22,876,800 | $22,104,900 | $21,514,800 | $20,674,700 | $19,504,800 |